The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-therapeutic dihydropyridimidine dehydrogenase (DPD) deficiency screening: Impact on fluoropyrimidine dose reduction at the second chemotherapy cycle and on early severe toxicity.
 
Côme De Metz
No Relationships to Disclose
 
Benjamin Hennart
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Pierre-Yves Cren
No Relationships to Disclose
 
Christophe Desauw
No Relationships to Disclose
 
Vincent Bourgeois
Honoraria - Roche; SERVIER
Consulting or Advisory Role - SERVIER
Speakers' Bureau - Merck; SERVIER
Travel, Accommodations, Expenses - Sanofi
 
Fredrik Laestadius
No Relationships to Disclose
 
Emilia Rad
No Relationships to Disclose
 
Loic Lebellec
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Aurelien Carnot
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Amgen; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Merck Serono; MSD Oncology